Resources

GUIDELINES ON THE USE OF THE SHORTER REGIMEN AND NEW DRUGS IN THE CLINICAL AND PROGRAMMATIC MANAGEMENT OF DRUG RESISTANT TUBERCULOSIS AND CO-INFECTIONS OF NIGERIA.

This document describes the steps necessary to implement shorter regimen and new drugs for DR­ TB treatment including diagnosis and bacterial confirmation of drug resistance, treatment regimen design, monitoring of treatment efficacy and safety, and programmatic evaluation.

NATIONAL STANDARD OPERATING PROCEDURES FOR TUBERCULOSIS LABORATORY DIAGNOSIS.

NATIONAL GUIDELINES ON BIOSAFETY FOR TB LABORATORIES.

STANDARD OPERATING PROCEDURES/INFORMATION, EDUCATION AND COMMUNICATION MATERIALS ON CHILDHOOD TUBERCULOSIS.

ORIENTATION MANUAL FOR HEALTH CARE PROVIDERS ON THE NEW
PAEDIATRIC ANTI - TUBERCULOUS DRUG FORMULATION

The content of this desk guide are in line with the National Tuberculosis, Leprosy and Buruli Ulcer Management and Control Guidelines as adapted from WHO childhood Tuberculosis (TB) and human immunodeficiency virus infection (HIV) case management guidelines (Sixth edition, 2015).This guide is a decision-aid and does not cover all possible scenarios related to the management of childhood TB